AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NOVN.SW
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Novartis AG stock downgraded after the last trading session.
(Updated on May 22, 2024)

Buy or Hold candidate since May 07, 2024 Gain 3.76% PDF

The Novartis AG stock price fell by -0.778% on the last day (Wednesday, 22nd May 2024) from 93.89 Fr to 93.16 Fr. During the last trading day the stock fluctuated 0.667% from a day low at 93.01 Fr to a day high of 93.63 Fr. The price has risen in 7 of the last 10 days and is up by 5.74% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -674 thousand shares and in total, 2 million shares were bought and sold for approximately 223.35 Fr million.

The stock lies in the upper part of a weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at 93.94 Fr will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.93% during the next 3 months and, with a 90% probability hold a price between 87.99 Fr and 96.69 Fr at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NOVN.SW Signals & Forecast

The Novartis AG stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately 93.27 Fr. On a fall, the stock will find some support from the long-term average at approximately 88.67 Fr. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 21, 2024, and so far it has fallen -0.778%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Wednesday, September 13, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Wednesday, September 13, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Novartis AG stock

Novartis AG finds support from accumulated volume at 90.00 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved 0.620 Fr between high and low, or 0.667%. For the last week, the stock has had daily average volatility of 0.86%.

Our recommended stop-loss: 89.83 Fr (-3.58%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (NOVN.SW) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Novartis AG to open at 93.27 Fr, and during the day (based on 14 day Average True Range), to move between 91.89 Fr and 94.43 Fr, which gives a possible trading interval of +/-1.27 Fr (+/-1.37%) up or down from last closing price. If Novartis AG takes out the full calculated possible swing range there will be an estimated 2.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 93.37 Fr (0.23%) than the support at 90.00 Fr (3.39%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novartis AG stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novartis AG stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.708 Buy Candidate Downgraded

Predicted Opening Price for Novartis AG of Thursday, May 23, 2024

Fair opening price May 23, 2024 Current price
93.27 Fr ( 0.114%) 93.16 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NOVN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 93.89 0.780 %
R2 93.65 0.526 %
R1 93.50 0.369 %
Current price: 93.16
Support S1 93.03 -0.140 %
S2 92.88 -0.297 %
S3 92.65 -0.551 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 93.89 0.784 %
R2 93.49 0.354 %
R1 93.37 0.225 %
Current price 93.16
Support S1 90.00 -3.39%
S2 88.94 -4.53%
S3 85.64 -8.07%

NOVN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 07, 2024 Mar 07, 2024 Mar 11, 2024 3.30 Fr 3.72%
2 Mar 09, 2023 Mar 09, 2023 Mar 13, 2023 3.20 Fr 4.28%
3 Mar 08, 2022 Mar 08, 2022 Mar 08, 2022 3.10 Fr 4.17%
4 Mar 04, 2021 Mar 04, 2021 Mar 04, 2021 3.00 Fr 3.84%
5 Jan 29, 2020 Mar 03, 2020 Mar 05, 2020 2.95 Fr 3.59%

FAQ

What is the symbol for Novartis AG Stock and on which exchange is it traded?
The symbol for Novartis AG is NOVN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Novartis AG Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novartis AG stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Novartis AG Stock?
Novartis AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novartis AG Stock.

What's the current price of Novartis AG Stock?
As of the end of day on the May 22, 2024, the price of an Novartis AG (NOVN.SW) share was 93.16 Fr.

What is the 52-week high and low for Novartis AG Stock?
The 52-week high for Novartis AG Stock is 94.77 Fr and the 52-week low is 83.00 Fr.

What is the market capitalization of Novartis AG Stock?
As of the May 22, 2024, the market capitalization of Novartis AG is 182.266B.

When is the next earnings date for Novartis AG?
The upcoming earnings date for Novartis AG is Jun 05, 2024.
Click to get the best stock tips daily for free!

About Novartis AG

Novartis AG Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops,... NOVN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT